Letters to the Editor

Guay DR . The emerging role of valproate in bipolar disorder and other psychiatric disorders. Pharmacotherapy 1995;15:631–47.

Post RM Ketter TA Denicoff K Pazzaglia PJ Leverich GS , Marangell LB, and others. The place of anticonvulsivant therapy in bipolar illness. Pharmacotherapy-Berlin. 1996;128:115–29.

Bruce LD , editor-in-chief. Compendium of pharmaceuticals and specialities. Ottawa: Canadian Pharmaceutical Association; 1999.

McEvoy GK , editor. American hospital formulary service drug information. Bethesda (MD): American Society of Health-System Pharmaceutic; 1999.

Carrigan PJ Papp K Schultz G Venable T . Bioavailability of valproate from divalproex sodium tablets. Abbott Laboratories, Intern study no F83–103, Chicago. (unpublished data).

Cloyd JC Kriel RL Jones-Saete CM Ong BY Janick JT , Remmel RP, and others. Comparison of sprinkle versus syrup formulations of valproate for bioavailability, tolerance and preference. J Pediatr 1992;120:634–8.

Bowden CL Brugger AM Swann AC Calabrese JR Janicak PG , Petty F, and others. Relation of serum valproate concentration to response in mania. Am J Psychiatry 1996;153:765–70.

Ebert D Albert R May A Merz A Murata H , Stosiek I, and others. The serotonin syndrome and psychosis-like side-effects of fluvoxamine in clinical use—an estimation of incidence. European Neuropsychopharmacology 1997;7:71–4.

Palmer KJ Benfield P . Fluvoxamine. An overview of its pharmacological properties and review of its therapeutic potential in non-depressive disorders. CNS Drugs 1994;1:57–87.

Hoehn-Saric R McLeod DR Hipsley PA . Effect of fluvoxamine on panic disorder. J Clin Psychopharmacol 1993;13:321–6.

Wallnofer A Guentert TW Eckemas SA Dingemanse J . Moclobemide and fluvoxamine coadministration: A prospective study in healthy volunteers to investigate the potential development of the “serotonin syndrome.” Human Psychopharmacol 1995;10:25–31.

McDougle CJ Goodman WK Leckman JF Barr LC Heninger GR Price LH . The efficacy of fluvoxamine in obsessive-compulsive disorder: Effects of comorbid chronic tic disorder. J Clin Psychopharmacol 1993;13:354–8.

Black DW Monahan P Gabel J . Fluvoxamine in the treatment of compulsive buying. J Clin Psychiatry 1997;58:159–63.

Andreason NC Wasck P . Adjustment disorders in adolescents and adults Arch Gen Psychiatry 1980;37:1166–70.

Strain JJ Newcom J Wolf D Fulop G Davis W . Considering changes in adjustment disorder. Hosp Community Psychiatry 1993;44:13–5.

Despland JN Monod L Ferrero F . Clinical relevance of adjustment disorder in DSM-III-R and DSM-IV. Compr Psychiatry 1995;36:454–60.

Gillis MC , editor-in-chief. Compendium of pharmaceuticals and specialties. 34th ed. Ottawa: Canadian Pharmacists Association; 1999. 665–6.

Beeber AR Manring JM Jr. , Psychosis following cyclobenzaprine use. J Clin Psychiatry 1983;44:151–2.

Fernandez HH Friedman JH . Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 1999;14(3):484–7.

Misra LK Erpenbach JE Hamlyn H Fuller WC . Quetiapine: A new typical antipsychotic [review]. South Dakota Journal of Medicine 1998;51(6):189–93.

Peuskens J Link CG . A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. Acta Psychiatrica Scand 1997;96(4):265–73.

Weller M Kornhuber J . Does clozapine cause neuroleptic malignant syndrome? J Clin Pschiatry 1993;54:70–1.

Thornberg SA Ereshefsky L . Neuroleptic malignant syndrome associated with clozapine monotherapy. Pharmacotherapy 1993;13:510–4.

Hasan S Buckley P . Novel antipsychotics and the neuroleptic malignant syndrome: A review and critique. Am J Psychiatry 1998;155:1113–6.

Bach C . Upon collective suicide: Clinical varieties, historical and artistic illustration. A psychopathological approach. Psychol Med Paris 1984;16:1999–2001.

Pozzi E . Il carisma malato. Il Peoples Temple e il suicidio collettivo di Jonestown. Napoli: Liguori; 1992. p 101–3.